10x Genomics Inc - Ordinary Shares - Class A
TXG
Market Cap$2.7B
Close$
$42.06
64.4% upside
Current Fair Value
64.4% upsideUndervalued by 64.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.70 Billion |
|---|---|
| Enterprise Value | $2.33 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-2.24 |
| Beta | 2.09 |
| Outstanding Shares | 105,651,593 |
| Avg 30 Day Volume | 2,040,972 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -10.23 |
|---|---|
| PEG | -56.41 |
| Price to Sales | 5.12 |
| Price to Book Ratio | 4.27 |
| Enterprise Value to Revenue | 3.73 |
| Enterprise Value to EBIT | -10.9 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About 10x Genomics Inc
CEO: Serge Saxonov